Journal article

Perspectives of targeting mTORC1–S6K1 in cardiovascular aging

  • Ming, Xiu-Fen Laboratory of Vascular Biology, Division of Physiology, Department of Medicine, University of Fribourg, Switzerland
  • Montani, Jean-Pierre Laboratory of Vascular Biology, Division of Physiology, Department of Medicine, University of Fribourg, Switzerland
  • Yang, Zhihong Laboratory of Vascular Biology, Division of Physiology, Department of Medicine, University of Fribourg, Switzerland
    25.01.2012
Published in:
  • Frontiers in Vascular Physiology. - 2012, vol. 3, p. 5
English The global population aging is accelerating and age-associated diseases including cardiovascular diseases become more challenging. The underlying mechanisms of aging and age-associated cardiovascular dysfunction remain elusive. There are substantial evidences demonstrating a pivotal role of the mammalian target of rapamycin complex 1 (mTORC1) and its down-stream effector S6K1 signaling in mammalian lifespan regulation and age-related diseases such as type II diabetes mellitus and cancer. The role of mTORC1–S6K1 in age-related cardiovascular diseases is, however, largely unknown and the available experimental results are controversial. This review article primarily summarizes the most recent advances toward understanding the role of mTORC1–S6K1 in cardiovascular aging and discusses the future perspectives of targeting mTORC1–S6K1 signaling as a healthy lifespan extension modality in anti-aging and anti-cardiovascular aging.
Faculty
Faculté des sciences et de médecine
Department
Département de Médecine
Language
  • English
Classification
Biology
License
License undefined
Identifiers
Persistent URL
https://folia.unifr.ch/unifr/documents/302482
Statistics

Document views: 18 File downloads:
  • yan_ptt.pdf: 1